SCHEMBL25480675

SCHEMBL25480675

Cc1ncccc1C(=O)Nc1c(C)c(Cl)cc2c1[nH]c1ccccc12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ICOSLG O75144 4/20 0.66
▸ ICOS Q9Y6W8 4/20 0.66
▸ CHUK O15111 2/20 0.66
▸ IKBKB O14920 1/20 0.66
▸ TYK2 P29597 1/20 0.66
▸ CLK1 P49759 1/20 0.66
▸ CLK2 P49760 1/20 0.66
▸ DYRK1A Q13627 1/20 0.66
▸ CLK4 Q9HAZ1 1/20 0.66
▸ PI4KB Q9UBF8 1/20 0.66
▸ KMT2A Q03164 5/20 0.49
▸ MEN1 O00255 4/20 0.49
▸ LMNA P02545 2/20 0.49
▸ POLB P06746 1/20 0.49
▸ MAPT P10636 4/20 0.45
▸ KDM4E B2RXH2 3/20 0.45
▸ VCP P55072 1/20 0.42
▸ TNFSF11 O14788 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ MAPK1 P28482 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17225471 0.90 CHUK (0.81) ICOSLGICOSCHUKIKBKBTYK2
SCHEMBL1802564 0.81 CHUK (0.77) ICOSLGICOSCHUKIKBKBTYK2
SCHEMBL30039188 0.80 CHUK (1.00) ICOSLGICOSCHUKIKBKBTYK2
SCHEMBL30492167 0.80 CHUK (1.00) ICOSLGICOSCHUKIKBKBTYK2
SCHEMBL1420073 0.80 CHUK (1.00) ICOSLGICOSCHUKIKBKBTYK2
SCHEMBL12619277 0.80 CHUK (0.75) ICOSLGICOSCHUKIKBKBTYK2
SCHEMBL1801454 0.80 CHUK (0.75) ICOSLGICOSCHUKIKBKBTYK2
SCHEMBL30342072 0.80 CHUK (1.00) ICOSLGICOSCHUKIKBKBTYK2
Hydrochloric Acid SCHEMBL18114522 0.79 CHUK (0.98) ICOSLGICOSCHUKIKBKBTYK2
SCHEMBL1798941 0.78 CHUK (0.84) ICOSLGICOSCHUKIKBKBTYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230250085-A1 QUINOXALINE COMPOUNDS AND USES THEREOF BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA 2023-08-10 — — US disclosed
US-11661411-B2 Quinoxaline compounds and uses thereof BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) 2023-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11661411-B2 Quinoxaline compounds and uses thereof NFKBIA, RELA, IKBKB ICOSLG 4734/4885ICOS 4768/4885CHUK 4/4885
US-20230250085-A1 QUINOXALINE COMPOUNDS AND USES THEREOF NFKBIA, RELA, IKBKB ICOSLG 4734/4885ICOS 4768/4885CHUK 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback